223 related articles for article (PubMed ID: 25572545)
1. Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Tamada T; Watanabe S; Nishimura H; Kanki A; Noda Y; Higaki A; Yamamoto A; Ito K
Radiol Med; 2015 Jun; 120(6):557-62. PubMed ID: 25572545
[TBL] [Abstract][Full Text] [Related]
2. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
3. Comments on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007/s11547-014-0492-y.
Endrikat J; Sieber MA; Agris J; Pietsch H
Radiol Med; 2016 Mar; 121(3):238-9. PubMed ID: 26576550
[No Abstract] [Full Text] [Related]
4. Response to the Comments by Dr. Endrikat et al. on the article "Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)" by Tomohiro Sato, Tsutomu Tamada, Shigeru Watanabe et al. DOI 10.1007/s11547-014-0492-y.
Sato T
Radiol Med; 2016 Mar; 121(3):240-1. PubMed ID: 26576549
[No Abstract] [Full Text] [Related]
5. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
6. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats.
Mühler A; Heinzelmann I; Weinmann HJ
Invest Radiol; 1994 Feb; 29(2):213-6. PubMed ID: 8169100
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.
Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ
PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
[TBL] [Abstract][Full Text] [Related]
9. NSF evaluation of gadolinium biodistribution in renally impaired rats: Using novel metabolic Gd2O3 nanoparticles coated with β-cyclodextrin (Gd2O3@PCD) in MR molecular imaging.
Ashouri H; Riyahi Alam N; Khoobi M; Haghgoo S; Rasouli Z; Gholami M
Magn Reson Imaging; 2024 Apr; 107():120-129. PubMed ID: 38215955
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
11. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
Tsuda N; Okada M; Murakami T
Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
[TBL] [Abstract][Full Text] [Related]
12. Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA.
Kim T; Murakami T; Hasuike Y; Gotoh M; Kato N; Takahashi M; Miyazawa T; Narumi Y; Monden M; Nakamura H
J Magn Reson Imaging; 1997; 7(4):683-8. PubMed ID: 9243389
[TBL] [Abstract][Full Text] [Related]
13. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
Tsuda N; Okada M; Murakami T
Eur J Radiol; 2010 Jan; 73(1):137-42. PubMed ID: 19026502
[TBL] [Abstract][Full Text] [Related]
14. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
Ma C; Liu A; Wang Y; Geng X; Hao L; Song Q; Sun B; Wang H; Zhao G
Life Sci; 2014 Jul; 108(2):104-8. PubMed ID: 24881519
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vivo dissociation of gadolinium chelates in renally impaired rats: a relaxometry study.
Fretellier N; Idée JM; Dencausse A; Karroum O; Guerret S; Poveda N; Jestin G; Factor C; Raynal I; Zamia P; Port M; Corot C
Invest Radiol; 2011 May; 46(5):292-300. PubMed ID: 21263333
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation.
Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H
Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574
[TBL] [Abstract][Full Text] [Related]
19. The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate.
Di Gregorio E; Ferrauto G; Furlan C; Lanzardo S; Nuzzi R; Gianolio E; Aime S
Invest Radiol; 2018 Mar; 53(3):167-172. PubMed ID: 28990973
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and excretion of 153Gd-labeled gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid following repeated intravenous administration to rats.
Mühler A; Weinmann HJ
Acad Radiol; 1995 Apr; 2(4):313-8. PubMed ID: 9419568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
